FLECTOR® Patch (diclofenac epolamine topical patch) 1.3%
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Acute Back Strain
Conditions
Acute Back Strain
Trial Timeline
Jan 1, 2010 → Mar 1, 2010
NCT ID
NCT01054820About FLECTOR® Patch (diclofenac epolamine topical patch) 1.3%
FLECTOR® Patch (diclofenac epolamine topical patch) 1.3% is a approved stage product being developed by Pfizer for Acute Back Strain. The current trial status is completed. This product is registered under clinical trial identifier NCT01054820. Target conditions include Acute Back Strain.
What happened to similar drugs?
20 of 20 similar drugs in Acute Back Strain were approved
Approved (20) Terminated (4) Active (0)
✅Modification of Prasugrel based on a biological assay + prasugrel / clopidogrelDaiichi SankyoApproved
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01054820 | Approved | Completed |
Competing Products
20 competing products in Acute Back Strain